smoking was reported to be the leading cause of OC. With this, a community based study was conducted to diagnose OC among the smokers. Methods: This is a community based ongoing research, since 01 March 2021. The study protocol was approved by the
Search Results
Tarun Chowdary Gogineni
Joshua Richter, Stephen J. Noga, and Robert Rifkin
advocacy groups, and others. In this commentary, we propose community oncology center partnerships as one cornerstone of the solution. Racial and ethnic minorities are underrepresented in oncology research despite disproportionate disease burden. Up to 20
Adrian Legaspi, Vanitha Vasudevan, Amit Sastry, Jeronimo Garcialopez de Llano, and Marice Ruiz-Conejo
malignancy managed with RACS in a community hospital. Methods: comparative study of the first 57patients treated with RACS for malignant tumors done from 6/17 to 7/19 in a community hospital. The data was then compared to the published literature. Two
Ravi B. Parikh, Ramy Sedhom, William J. Ferrell, Katherine Villarin, Kara Berwanger, Bethann Scarborough, Randall Oyer, Pallavi Kumar, Niharika Ganta, Shanthi Sivendran, Jinbo Chen, Kevin G. Volpp, and Justin E. Bekelman
-based criteria to clinicians on (1) PC referrals and completed visits, and (2) quality of life. Methods: This 2-arm pragmatic randomized trial, conducted in a large, rural community oncology practice, randomizes 4 clinician-pods, consisting of approximately 250
Gabriela Abigail Villanueva
marginalized groups. Our objective is to provide quality palliative care to oncology Hispanic patients along the Mexico-US border by using community health workers (promotoras) to deliver a comprehensive and culturally sensitive educational intervention. We
Margaret A. O'Grady, Elena Gitelson, Ramona F. Swaby, Lori J. Goldstein, Elaine Sein, Patricia Keeley, Bonnie Miller, Tianyu Li, Alan Weinstein, and Steven J. Cohen
Fox Chase Cancer Center Partners (FCCCP) is a community hospital/academic partnership consisting of 25 hospitals in the Delaware Valley. Originally created in 1986, FCCCP promotes quality community cancer care through education, quality assurance, and access to clinical trial research. An important aspect of quality assurance is a yearly medical oncology audit that benchmarks quality indicators and guidelines and provides a roadmap for quality improvement initiatives in the community oncology clinical office setting. Each year, the FCCCP team and the Partner Medical Oncologists build disease site- and stage-specific indicators based on National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology. Concordance with multiple indicators is assessed on 20 charts from each community practice. A report for each FCCCP medical oncology practice summarizes documentation, screening recommendations, new drug use, and research trends in a particular disease site. Descriptive statistics reflect indicators met, number of new cases seen per year, number of disease site cases from tumor registry information, and clinical trial accrual total. Education and documentation tools are provided to physicians and oncology office nursing staff. The FCCCP Clinical Operations Team, consisting of medical oncologists and oncology-certified nurses, has conducted quality audits in medical oncology offices for 7 years using NCCN-derived indicators. Successful audits comprising gastric, colorectal, and breast cancer have been the focus of recent evaluations. For the 2005 stage II/III breast cancer evaluation, mean compliance per parameter was 88%, with 15 of 16 practices achieving mean compliance greater than 80%. A large-scale quality assurance audit in a community cancer partner network is feasible. Recent evaluation of localized breast cancer shows high compliance with guidelines and identifies areas for focused education. Partnership between academic and community oncologists produces a quality review process that is broadly applicable and adaptable to changing medical knowledge.
Bianca Lewis, Caitlin R. Meeker, Elizabeth Handorf, Kelly Filchner, Rino Seedor, Jennifer S. Winn, Lori J. Goldstein, and Efrat Dotan
analysis, we sought to describe the psychosocial profile of older community patients with MBC, and investigate the correlation between psychosocial factors and presence of other GA abnormalities. Methods: This study included hands-on experience
Howland E. Crosswell, Kaitlin N. Bomar, Nicole Vickery, Kristina Stoeppler-Biege, Terra D. Spann, and Robert D. Siegel
approximately 80% of the nearly 70,000 AYA patients diagnosed annually in the United States are seen and/or cared for in the community, understanding and implementing AYA care delivery in nonacademic settings is important. Recent updates to the NCCN Clinical
Shivan J. Mehta, Sanjay Palat, Catherine Reitz, Evelyn Okorie, Caitlin McDonald, Pamela A. Shaw, Karen Glanz, and David A Asch
Background : Effective prevention and screening exists for colorectal cancer (CRC) but is underutilized, particularly in community health settings. Colonoscopy and fecal immunochemical testing (FIT) are both considered top-tier tests according
Rowena N. Schwartz, Kirby J. Eng, Deborah A. Frieze, Tracy K. Gosselin, Niesha Griffith, Amy Hatfield Seung, Jennifer M. Hinkel, Philip E. Johnson, Shirley A. Johnson, Edward C. Li, Audrea Hotsko Szabatura, and Michael K. Wong
standard and may include models such as mail-order distribution (the traditional model for specialty pharmacy) or distribution from a community pharmacy. One historic feature of specialty pharmacy is the focus on diseases that are chronic and low
